Magnasense AB

NEW
FRA:52Q (Sweden)   Ordinary Shares
€ 0.017 (0%) Mar 31
At Loss
Market Cap:
€ 2.03M ($ 2.19M)
Enterprise V:
€ 6.07M ($ 6.55M)
Volume:
-
Avg Vol (2M):
475.00
Trade In:
What is a stock summary page? Click here for an overview.

Business Description

Description
AegirBio AB is a Swedish diagnostic company, specializes in developing a home testing platform for oral health, therapeutic drug monitoring and infectious diseases. The current product line up includes the Veritope technology, featuring intact natalizumab in MS, along with the MagniaReader designed for both research and veterinary applications.
Name Current Vs Industry Vs History
Cash-To-Debt 0.01
Equity-to-Asset -1.19
Debt-to-Equity -1.14
Debt-to-EBITDA -1.17
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 48.2
3-Year EPS without NRI Growth Rate 40.8
3-Year FCF Growth Rate 59.7

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.32
Quick Ratio 0.32
Cash Ratio 0.01

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -48.9
Shareholder Yield % -71

Profitability Rank

Name Current Vs Industry Vs History
ROA % -106.41
ROIC % -86.63
3-Year ROIIC % -11.41
ROC (Joel Greenblatt) % -1466.99
ROCE % -117.74

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -1.74
EV-to-EBITDA -1.74
EV-to-FCF -2.27
Earnings Yield (Greenblatt) % -57.55
FCF Yield % -125.83

Financials (Next Earnings Date:2025-05-16 Est.)

FRA:52Q's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Magnasense AB Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €)
EPS (TTM) (€) -0.101
Beta 1.22
3-Year Sharpe Ratio -0.55
3-Year Sortino Ratio -0.94
Volatility % 172.06
14-Day RSI 60.11
14-Day ATR (€) 0.00132
20-Day SMA (€) 0.015805
12-1 Month Momentum % -71.78
52-Week Range (€) 0.0045 - 0.0725
Shares Outstanding (Mil) 84.76

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Magnasense AB Filings

Filing Date Document Date Form
No Filing Data

Magnasense AB Stock Events

Financials Calendars
Event Date Price (€)
No Event Data

Magnasense AB Frequently Asked Questions

What is Magnasense AB(FRA:52Q)'s stock price today?
The current price of FRA:52Q is €0.02. The 52 week high of FRA:52Q is €0.07 and 52 week low is €0.00.
When is next earnings date of Magnasense AB(FRA:52Q)?
The next earnings date of Magnasense AB(FRA:52Q) is 2025-05-16 Est..
Does Magnasense AB(FRA:52Q) pay dividends? If so, how much?
Magnasense AB(FRA:52Q) does not pay dividend.

Press Release

Subject Date
No Press Release